Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1864

1.

Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.

Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D.

Pediatrics. 2006 Jul;118(1):e139-50.

PMID:
16818529
3.

Regression of language and non-language skills in pervasive developmental disorders.

Meilleur AA, Fombonne E.

J Intellect Disabil Res. 2009 Feb;53(2):115-24. doi: 10.1111/j.1365-2788.2008.01134.x. Epub 2008 Nov 27.

PMID:
19054269
4.

Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States.

Rosenthal J, Rodewald L, McCauley M, Berman S, Irigoyen M, Sawyer M, Yusuf H, Davis R, Kalton G.

Pediatrics. 2004 Apr;113(4):e296-302.

PMID:
15060256
5.

No evidence for a new variant of measles-mumps-rubella-induced autism.

Fombonne E, Chakrabarti S.

Pediatrics. 2001 Oct;108(4):E58.

PMID:
11581466
6.

Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.

France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R; Vaccine Safety Datalink Team.

Pediatrics. 2008 Mar;121(3):e687-92. doi: 10.1542/peds.2007-1578.

PMID:
18310189
7.

Autism spectrum disorders in young children: effect of changes in diagnostic practices.

Nassar N, Dixon G, Bourke J, Bower C, Glasson E, de Klerk N, Leonard H.

Int J Epidemiol. 2009 Oct;38(5):1245-54. doi: 10.1093/ije/dyp260. Epub 2009 Sep 7.

PMID:
19737795
8.

[Prevalence of pervasive developmental disorders. A review].

Lenoir P, Bodier C, Desombre H, Malvy J, Abert B, Ould Taleb M, Sauvage D.

Encephale. 2009 Feb;35(1):36-42. doi: 10.1016/j.encep.2007.12.011. Epub 2008 Sep 23. Review. French.

PMID:
19250992
10.

The incidence and prevalence of pervasive developmental disorders: a Danish population-based study.

Lauritsen MB, Pedersen CB, Mortensen PB.

Psychol Med. 2004 Oct;34(7):1339-46.

PMID:
15697060
11.

Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine.

LeBaron CW, Bi D, Sullivan BJ, Beck C, Gargiullo P.

Pediatrics. 2006 Oct;118(4):1422-30.

PMID:
17015532
12.

Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus.

DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, Vadheim CM, Black SB, Shinefield HR, Davis RL, Bohlke K; Vaccine Safety Datalink Team.

Pediatrics. 2001 Dec;108(6):E112.

PMID:
11731639
13.

The genetics of autism.

Muhle R, Trentacoste SV, Rapin I.

Pediatrics. 2004 May;113(5):e472-86. Review.

PMID:
15121991
14.
15.

Risk factors for delayed immunization against measles, mumps, and rubella in Colorado two-year-olds.

Miller LA, Hoffman RE, BarĂ³n AE, Marine WM, Melinkovich P.

Pediatrics. 1994 Aug;94(2 Pt 1):213-9.

PMID:
8036076
16.

A population-based study of measles, mumps, and rubella vaccination and autism.

Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M.

N Engl J Med. 2002 Nov 7;347(19):1477-82.

17.

Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.

Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B.

Pediatrics. 2004 Sep;114(3):584-91.

PMID:
15342825
18.

The rise in autism and the mercury myth.

Scahill L, Bearss K.

J Child Adolesc Psychiatr Nurs. 2009 Feb;22(1):51-3. doi: 10.1111/j.1744-6171.2008.00152.x. Review. No abstract available.

PMID:
19200293
19.

Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection.

Olesen AB, Juul S, Thestrup-Pedersen K.

Acta Derm Venereol. 2003;83(6):445-50.

20.

No effect of MMR withdrawal on the incidence of autism: a total population study.

Honda H, Shimizu Y, Rutter M.

J Child Psychol Psychiatry. 2005 Jun;46(6):572-9.

PMID:
15877763

Supplemental Content

Support Center